Imanova Ltd - Company Review
Imanova Ltd - Company ReviewSummary
Imanova Ltd (Imanova) is a provider of imaging services. It offers wide range of services such as development of imaging biomarkers, clinical imaging services, preclinical imaging services, analysis and consultancy services, and pilot grants programs. The company’s preclinical imaging services include evaluation and characterization of novel radiotracers and drugs; development and assessment of imaging protocols; and other services. Imanova is a joint venture of Imperial College London; UK's Medical Research Council; University College London and King's College London. The company works in partnership with academic, research and commercial organizations. Imanova is headquartered in London, the UK.
This comprehensive company report of Imanova Ltd provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.